# 年龄标准化的睾酮在 B 系列时达到峰值，对于男性创业公司创始人来说。

发布时间：2024年11月05日

`其他` `生物医学`

> Age Normalized Testosterone Peaks at Series B for Male Startup Founders

# 摘要

> 摘要：在对 107 位男性 Y Combinator 创始人的研究中，发现了年龄标准化睾酮与公司阶段之间令人惊讶的相关性。睾酮是一种与自信、主导地位和动力相关的激素，从种子前到种子期增加了 55.7％，在 B 轮达到峰值，水平比种子前高 99.6％。在 B 轮融资后，观察到睾酮下降了 42.2％，同时皮质醇水平飙升。这种年龄标准化的生物标志物分析支持双激素假说，表明早期创业成功培养了主导和自信的感觉，而后期的压力和紧张削弱了这些感觉。对数据的另一种解释（这表明有进行纵向研究的机会）是，睾酮水平较高的男性创始人更有可能筹集到更大规模的资金。

> 
Abstract:In a study of 107 male Y Combinator founders, a surprising correlation between age-normalized testosterone and company stage was uncovered. Testosterone, a hormone associated with confidence, dominance, and drive, increased by 55.7% from pre-seed to seed funding, peaking at the Series B stage, where levels were 99.6% higher than pre-seed. After series B funding, testosterone was observed to drop by 42.2%, coinciding with a spike in cortisol levels. This age-normalized biomarker analysis supports the dual-hormone hypothesis, illustrating that early startup success fosters feelings of dominance and confidence, while later-stage pressures and stresses erode these feelings. An alternative interpretation of the data, which suggests the opportunity for a longitudinal study, is that male founders with higher testosterone are more likely to raise larger rounds of funding.
    

[Arxiv](https://arxiv.org/pdf/2411.03361)